Emerald Advisers’s Imago BioSciences IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-853,637
Closed -$12.8M – 266
2022
Q3
$12.8M Buy
853,637
+30,575
+4% +$496K 0.66% 72
2022
Q2
$11M Buy
823,062
+206,694
+34% +$3.28M 0.57% 77
2022
Q1
$11.9M Buy
616,368
+40,209
+7% +$834K 0.45% 86
2021
Q4
$13.7M Buy
576,159
+4,130
+0.7% +$95.7K 0.5% 78
2021
Q3
$11.5M Buy
+572,029
New +$12.3M 0.42% 92

Other funds holding IMGO

Emerald Advisers's IMGO Position: Q4 2022 in Review

Emerald Advisers sold out of Imago BioSciences (IMGO) in Q4 2022, closing a stake of 853,637 shares — an estimated $12.8M sold.

Emerald Advisers first reported a position in IMGO in Q3 2021 and held it in 5 quarters. The position peaked at $13.7M in Q4 2021. 106 funds tracked by Wall St. Rank hold IMGO as of Q4 2022.

  • Emerald Advisers reported no remaining Imago BioSciences position as of Q4 2022 after selling out during the quarter.
  • Emerald Advisers sold 853,637 Imago BioSciences shares in Q4 2022, an estimated $12.8M.
  • Emerald Advisers first reported a position in Imago BioSciences in Q3 2021 and held it in 5 quarters.
  • Emerald Advisers's Imago BioSciences position peaked at $13.7M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Imago BioSciences as of Q4 2022.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.